Precision cancer therapies for colon cancer

Colon cancer is the 3rd most common cancer occurring in men and women nationwide. This year, an estimated 149,500 people will be diagnosed with colorectal cancer in the United States. At The University of Kansas Cancer Center, the region's only National Cancer Institute-designated comprehensive cancer center, we take a personalized approach to colon cancer treatment and provide precision cancer therapies specific to each patient. The first step in caring for you begins the moment you call.

Request an appointment today.

888-907-4791

Multidisciplinary expertise

Our multidisciplinary team of colon cancer specialists designs effective personalized treatment for each patient based on his or her genetic, environmental and lifestyle factors. These precision cancer therapies integrate a patient's tumor molecular data into all treatment decisions.

Nationally renowned experts

Our fellowship-trained physicians provide the most advanced medical and surgical care for colon cancer patients, and access to nationally recognized leading-edge treatment through clinical trials. Our nationally renowned physicians/investigators conduct pivotal research that propels colon cancer care forward, leading to improved treatments and innovative patient care. We also provide a gastrointestinal high-risk clinic for patients at increased risk for the disease.

Why choose The University of Kansas Cancer Center

The University of Kansas Cancer Center is part of a nationwide network of select cancer research centers established by the National Cancer Institute, part of the National Institutes of Health. NCI-designated cancer centers achieve patient outcomes that are 25% better than those of other centers.
Our multidisciplinary colon cancer team comprises more than 40 colorectal specialists in gastroenterology, medical oncology, radiation oncology, surgical oncology, interventional radiology and research. As the region's largest cancer center, we have 13 locations throughout Kansas City.
We are 1 of fewer than 60 NCI-designated comprehensive cancer centers nationwide. NCI-designated cancer centers are the backbone of innovative research and patient care across the country. We treat patients from across the U.S. and around the globe at our multiple locations. Since 2012, we have diagnosed and treated patients from 50 states and 26 countries.